Where the mind is without fear…
TK Kanchana, Director-General, Organisation of Pharmaceutical Producers of India (OPPI) talks about the trends which are most…
Author
A year of opportunities and challenges
Vikas Bhadoria, Senior Partner, Mc Kinsey and Vivek Arora, Associate Partner, Mc Kinsey, talk about how the global industry is at…
Business trends in 2017
Utkarsh Palnitkar, Partner, National Head – Infrastructure, Government & Healthcare and National Head – Life Sciences…
Dominant business trends in 2017
Ameesh Masurekar, Director, AIOCD Pharmasofttech AWACS, talks about the prevalence of online retail, therapeutic and regulatory…
Indian pharma landscape in 2017
Antal International takes a closer look at the business trends that could be game changers for India's growing pharmaceutical…
Pharma cos need to realign biz models
Pharma companies should focus on high-performing therapeutic area and geographic markets and they need to realign their business…
Fixed dose combination drugs – to be banned or not to be banned
Ajay Bhargava, Vanita Bhargava and Aseem Chaturvedi explain how the FDC ban notification has adversely affected the pharma…
Trends in global and Indian pharma industry
Uttam Jain, Director, Neon Laboratories, elaborates on how the pharma industry will register positive growth trends in the next…
Pharma cos brace up for a paradigm shift
With vast and quick change in culture and various global platforms, the industry is to witness a growing trend of digitisation in…
Outlook for global medicines through 2021
Growth in spending on medicines in major pharmerging markets has slowed from 2–10 percentage points over the past five years and…